Search - tctmd.com

Displaying 641 - 655 of 655

Sort: Relevancy | Date

News Daily News

ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9

Michael O'Riordan

April 02, 2016

News Daily News

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Michael O'Riordan

February 15, 2016

News Daily News

Según un Informe los Datos Avalan Tratar el Riesgo de los Pacientes No las Dianas de Colesterol LBD

Michael O'Riordan

February 15, 2016

News Daily News

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Michael O'Riordan

February 15, 2016

News Daily News

Análisis del Estudio Mesa: Las Imágenes Ateroscleróticas ‘Negativas’ Minimizan el Riesgo de ECV a los 10 Años

Michael O'Riordan

January 28, 2016

News Daily News

“阴性”动脉粥样硬化成像结果使 10 年心血管疾病风险下降：MESA 分析

Michael O'Riordan

January 28, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Daily News

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

Caitlin E. Cox

August 26, 2011

News Daily News

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

L.A. McKeown

May 06, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

News Industry News

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

CME

Advertisement

ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Según un Informe los Datos Avalan Tratar el Riesgo de los Pacientes No las Dianas de Colesterol LBD

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Análisis del Estudio Mesa: Las Imágenes Ateroscleróticas ‘Negativas’ Minimizan el Riesgo de ECV a los 10 Años

“阴性”动脉粥样硬化成像结果使 10 年心血管疾病风险下降：MESA 分析

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

ACT Published: Definitive Results Nix NAC for Preventing Kidney Damage

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content